Navigation Links
Lanx, Inc. Announces Aspen™ Spinous Process Fixation System Clinical Data at IMAST
Date:7/25/2011

BROOMFIELD, Colo., July 25, 2011 /PRNewswire/ -- Lanx®, Inc., a privately held medical device company focused on developing and commercializing innovative devices for spinal surgery, announced its Aspen™ Spinous Process Fixation System (Aspen) was featured in two poster presentations at The 18th International Meeting on Advanced Spine Techniques (IMAST) in Copenhagen, Denmark, July 13th to 16th.

Dan Gladney, Chief Executive Officer, Lanx, commented, "These scientific sessions at IMAST add to our growing body of data that continue to validate the versatility and efficacy of the Aspen system as a viable alternative to pedicle screw-rod fixation, as well as an effective adjunct to fusion. We see great opportunity in the spinous process fixation market and plan to leverage our leadership position to expand our platform with this proven, proprietary technology."

At the meeting, Dr. Mitchell Hardenbrook of The Boston Spine Group in collaboration with Colorado State University presented "Rigid Spinous Process System Fixation vs. Pedicle Screw Fixation in a Posterolateral Lumbar Arthrodesis Construct – Comparison of Fusion Rates." In this study, 24 sheep underwent a posterolateral fusion procedure at L5-L6, with autograft placed between the transverse processes. Twelve received the Aspen device and 12 received a bilateral pedicle screw-rod construct. Within 6 months following surgery CT analysis showed 12 of 12 sheep in the Aspen device group with robust bridging bone on at least one side, whereas only 7 of 12 in the pedicle screw group showed the same degree of bridging bone on at least one side.

Also at the meeting, Dr. Dean G. Karahalios of North Shore University Health System in collaboration with Barrow Neurological Institute presented "Biomechanics of Lumbar Facet Screws and Interspinous Anchor." The study compared the biomechanics of five different constructs combining facet screws, pedicle screws and the Aspen device, evaluating flexion-extension, lateral bending and axial rotation. In the combined average range of motion, both the Aspen device with bilateral facet screws and bilateral pedicle screws provided statistically superior stability.

To date, over 800 spine surgeons have used the Aspen system in nearly 20,000 implantations to achieve lumbar fusion in a less invasive manner than pedicle screws. The system includes a proprietary spiked fixation plate designed to be rigidly affixed to the spinous processes with the use of specialized surgical instrumentation. The unique central barrel allows the device to share the weight found in the lumbar and thoracic spine, while its hollow and fenestrated design serves as a bone graft containment chamber to facilitate fusion.

The Aspen system is intended for single level use in the thoracic or lumbar spine (T1-S1) for the treatment of degenerative disc disease, spondylolisthesis, spinal trauma or spinal tumor. The Aspen system is currently being used in a wide range of surgical applications including posterior fusions and interbody fusions.

Lanx markets a full line of spine stabilization technologies. For more information about the Aspen system or Lanx, please visit www.lanx.com.

About Lanx, Inc.Lanx is one of the largest and fastest growing privately held global spine companies. The Company was founded by a team of experienced medical device professionals and engineers in 2003 to improve the quality of spine care and provide surgeons with innovative products. Lanx develops and markets a full line of fusion technologies with a focus on minimally invasive and biologics products. The Company is headquartered in Broomfield, CO. More information on Lanx and its spinal surgery products can be found at www.lanx.com.Company Contact:

Media / Investors:Steve Deitsch

Kim Muscara / Nick LaudicoChief Financial Officer

(646) 536-7011/ 7030(303) 443-7500

kmuscara@theruthgroup.comsteve.deitsch@lanx.com

nlaudico@theruthgroup.com
'/>"/>

SOURCE Lanx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lanx, Inc. Announces Launch of Epic™ Anterior Thoracolumbar Plating System
2. Lanx, Inc. Appoints Dan Gladney Chief Executive Officer
3. Prasco® Announces Authorized Generic Agreement with Shionogi Inc.
4. Cornerstone Pharmaceuticals Announces The Journal of Molecular Medicines Publication of Research Showing Selective Inhibition of Cancer Cell Energy Metabolism With Its Novel Lipoate Derivative Compounds
5. SurgiCount Medical Announces Expanded Honor Roll Hospital Users, Landmark Product Usage Milestones Achieved
6. Valeant Pharmaceuticals Announces Approval of Sublinox® in Canada
7. Taiho Pharmaceutical Announces Results of Randomized Phase II Clinical Trial with Novel Antitumor Agent TAS-102
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2011 Financial Results
9. China Nuvo Solar Announces Definitive Agreement Signed to Acquire Medical Products company SurgLine, Inc.
10. Delcath Systems, Inc. Announces the Completion of Common Stock Offering
11. Misonix Announces Settlement of PuriCore Litigation, Including Entry into a U.S. Distribution Agreement for PuriCores Advanced Wound Care Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... N.C. , June 24, 2016  Consumers ... decisions and regulators/payers have placed more emphasis on ... environment, patient support programs in the pharmaceutical industry ... patients, medications. Consequently, pharmaceutical companies are focusing on ... they are providing products and services that improve ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... PawPaws brand pet supplements owned by Whole Health ... the health of felines. The formula is all-natural and is made from Chinese herbs ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):